Emba Medical said today it won CE Mark approval in the European Union for its Hourglass peripheral embolization plug device. The Dublin, Ireland-based embolization plug maker said the device features over-the-wire delivery, which the company claims increases precision of placement. “This is the 1st integrated, over-the-wire device designed for peripheral embolization procedures. The goal with over-the-wire […]
June 24, 2014 by Arezu Sarvestani
California-based EMBA Medical is still working on a $3 million equity funding round, according to recently updated SEC filings.
The company has been flying below the radar for months, with almost no online presence and very little known about its business, but trademark filings say that EMBA develops "medical devices, namely, devices for use in performing chemoembolization and radioembolization procedures."
EMBA Medical is about 1/3 of the way through a $3 million funding round with 16 listed, but unnamed, investors participating, according to a company SEC filing. EMBA has raised about $0.9 million so far through sales of equity, which began July 10.